Knoll Capital Management, LLC
Knoll Capital Management, LLC reported 37 US-listed holdings worth $214.3 million in its 13F for the quarter ended 30 June 2026, filed 10 September 2026. Its largest: Biohaven Pharmactl Hldg Co L (16.3%), Meiragtx Holdings PLC (7.9%) and Sprott Asset Management LP (5.4%). Against the quarter before, it opened 1 position, added to 5, trimmed 0 and sold out of 1.
The 14 largest of its 37 positions, each sized by its share of the reported holdings, coloured by the change in shares against Q1 2026.
What the fund reported holding at each quarter's end; hover a bar for the number of positions
What its reported holdings returned
Held through each quarter, the holdings it reported returned -6.8% over the 7 quarters to 30 June 2026, against +30.2% for the S&P 500.
Not the fund's own return: each 13F's holdings are kept unchanged until the next one, so trades inside a quarter, dividends, cash and fees are left out. A rough guide to how its picks have done over time.
What it did on the quarter
Its positions against its 13F for the quarter to 31 March 2026; a change under 0.1% of a position counts as held
Opened 1
- Abivax SA ABVX$4.7 million
Added to 5
- Ocular Therapeutix Inc. OCUL+550,000 shares · +92%
- Elicio Therapeutics Inc. ELTX+581,042 shares · +92%
- Nuvation Bio Inc. NUVB+100,000 shares · +7%
- Biohaven Pharmactl Hldg Co L+23,918 shares · +1%
- Pharming Group NV PHAR+34 shares · +1%
Sold out of 1
- Cardiol Therapeutics Inc. CRDL$135,000 last quarter
What it holds
| Company | Shares | Value | Of its book | Change in shares |
|---|---|---|---|---|
| Biohaven Pharmactl Hldg Co L | 2.4M | $35.0 million | 16.33% | +23.9K |
| Meiragtx Holdings PLC MGTX | 1.2M | $16.9 million | 7.88% | no change |
| Sprott Asset Management LP PHYS | 387.1K | $11.7 million | 5.45% | no change |
| Aldeyra Therapeutics Inc. ALDX | 5.5M | $11.7 million | 5.44% | no change |
| Ocular Therapeutix Inc. OCUL | 1.2M | $11.3 million | 5.27% | +550.0K |
| Royal Gold Inc. RGLD | 52.8K | $10.5 million | 4.91% | no change |
| Entera Bio Ltd ENTX | 5.9M | $10.4 million | 4.86% | no change |
| Nuvation Bio Inc. NUVB | 1.6M | $9.1 million | 4.24% | +100.0K |
| Agnico Eagle Mines Ltd AEM | 52.8K | $8.2 million | 3.82% | no change |
| Seabridge Gold Inc. SA | 317.0K | $8.2 million | 3.81% | no change |
| Kinross Gold Corp. KGC | 320.0K | $7.6 million | 3.53% | no change |
| Osisko Gold Royalties Ltd OR | 225.0K | $7.1 million | 3.32% | no change |
| SSR Mining in SSRM | 245.0K | $6.9 million | 3.23% | no change |
| Franco Nev Corp. FNV | 32.0K | $6.7 million | 3.11% | no change |
| Centerra Gold Inc. CGAU | 359.0K | $5.7 million | 2.66% | no change |
| Booz Allen Hamilton Holding Corp. BAH | 13.0K | $5.7 million | 2.66% | no change |
| Elicio Therapeutics Inc. ELTX | 1.2M | $4.7 million | 2.21% | +581.0K |
| Abivax SA ABVX | 35.0K | $4.7 million | 2.18% | new |
| Pan Amern Silver Corp. PAAS | 100.0K | $4.5 million | 2.09% | no change |
| Sprott Physical Silver Trust PSLV | 222.2K | $4.2 million | 1.96% | no change |
| Triple Flag Precious Metal TFPM | 115.0K | $3.4 million | 1.61% | no change |
| Abeona Therapeutics Inc. ABEO | 485.5K | $3.0 million | 1.40% | no change |
| Gold Royalty Corp. GROY | 1.0M | $2.8 million | 1.29% | no change |
| New Pac Metals Corp. NEWP | 485.0K | $1.9 million | 0.91% | no change |
| iShares Trust ITA | 7.7K | $1.9 million | 0.87% | no change |
| Philip Morris International Inc. PM | 10.0K | $1.8 million | 0.84% | no change |
| Coeur Mining, Inc. CDE | 96.1K | $1.6 million | 0.73% | no change |
| Alamos Gold Inc. New AGI | 50.0K | $1.5 million | 0.71% | no change |
| Wheaton Precious Metals Corp. WPM | 12.5K | $1.4 million | 0.66% | no change |
| Northrop Grumman Corp. NOC | 2.2K | $1.1 million | 0.51% | no change |
| Elemental Rty Corp. ELE | 50.0K | $873,000 | 0.41% | no change |
| Versamet Royalties Corp VMET | 66.6K | $820,668 | 0.38% | no change |
| Dakota Gold Corp. DC | 122.9K | $523,643 | 0.24% | no change |
| Amrize Ltd AMRZ | 9.2K | $489,027 | 0.23% | no change |
| Altimmune, Inc. (alt) ALT | 160.0K | $486,400 | 0.23% | no change |
| Pharming Group NV PHAR | 4.1K | $56,823 | 0.03% | +34 |
| Orgenesis, Inc. | 50.6K | $20,823 | 0.01% | no change |